NASDAQ: BHST
Bioharvest Sciences Inc Stock

$5.77+0.09 (+1.58%)
Updated Feb 7, 2025
BHST Price
$5.77
Fair Value Price
N/A
Market Cap
$99.96M
52 Week Low
$4.72
52 Week High
$6.85
P/E
N/A
P/B
24.15x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
5.24
Operating Cash Flow
N/A
Beta
-0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine BHST's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Value
C
Growth
C
Momentum
C
Sentiment
C
Safety
F
Financials
D
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
BHST
Ranked
#226 of 556

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important BHST news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

–
Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BHST scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BHST is poor value based on its book value relative to its share price (24.15x), compared to the US Biotechnology industry average (4.94x)
P/B vs Industry Valuation
BHST's short-term liabilities ($9.93M) exceed its short-term assets ($7.98M)
Short-term Liabilities Financials
BHST's long-term liabilities ($11.76M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more BHST due diligence checks available for Premium users.

Valuation

BHST price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
24.15x
Industry
4.94x
BHST is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BHST's financial health

Profit margin

Revenue
$6.5M
Net Income
-$2.7M
Profit Margin
-41.1%

Assets to liabilities

Assets
$25.8M
Liabilities
$21.7M
Debt to equity
5.24
BHST's short-term liabilities ($9.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BHST's long-term liabilities ($11.76M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BHST's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.8M
Investing
-$472.0k
Financing
-$164.0k

BHST vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
BHSTC$99.96M+1.60%N/A24.15x
ALGSC$98.77M+0.11%-3.76x1.97x
ANROD$98.44M-7.59%-0.74x0.60x
ANIXC$101.74M-0.94%-8.10x5.09x
VORD$96.83M-6.00%-0.86x1.33x

Bioharvest Sciences Stock FAQ

What is Bioharvest Sciences's quote symbol?

(NASDAQ: BHST) Bioharvest Sciences trades on the NASDAQ under the ticker symbol BHST. Bioharvest Sciences stock quotes can also be displayed as NASDAQ: BHST.

If you're new to stock investing, here's how to buy Bioharvest Sciences stock.

What is the 52 week high and low for Bioharvest Sciences (NASDAQ: BHST)?

(NASDAQ: BHST) Bioharvest Sciences's 52-week high was $6.85, and its 52-week low was $4.72. It is currently -15.78% from its 52-week high and 22.12% from its 52-week low.

How much is Bioharvest Sciences's stock price per share?

(NASDAQ: BHST) Bioharvest Sciences stock price per share is $5.77 today (as of Feb 7, 2025).

What is Bioharvest Sciences's Market Cap?

(NASDAQ: BHST) Bioharvest Sciences's market cap is $99.96M, as of Feb 8, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Bioharvest Sciences's market cap is calculated by multiplying BHST's current stock price of $5.77 by BHST's total outstanding shares of 17,327,716.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.